New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
September 29, 2009
08:36 EDTCERS
theflyonthewall.com: Cerus to present design for Phase III trial of INTERCEPT Blood System
Cerus Corp. announced that it will present the proposed design for a U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets at the upcoming November meeting of the FDA's Blood Products Advisory Committee. The Committee meeting is open to the public and discussion of the INTERCEPT trial is scheduled to occur the afternoon of November 16. :theflyonthewall.com



News For CERS From The Last 14 Days
Check below for free stories on CERS the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 1, 2012
08:33 EDTCERS
theflyonthewall.com: Cerus, Ilex BioTech report INTERCEPT system approvals in Israel
Cerus Corporation and Ilex BioTech Ltd. announced that the INTERCEPT Blood System has received regulatory approval in Israel for the treatment of platelets and plasma intended for transfusion. The INTERCEPT Blood System is designed to provide increased protection from a broad range of transfusion-transmitted pathogens, including bacteria and emerging pathogens such as the dengue and chikungunya viruses. :theflyonthewall.com